Press Releases

Hogan Lovells advises Gilead Sciences in long-acting HIV therapy collaboration agreement with Merck

Northern Virginia, Washington D.C., Brussels, 17 March 2021 – A team from global law firm Hogan Lovells has advised Gilead Sciences on its recently announced collaboration agreement with...

Press Releases

Hogan Lovells welcomes the New Year and 25 new partner and 60 new counsel promotions

LONDON and WASHINGTON, D.C., 5 January 2021 – Global law firm Hogan Lovells today announced that 25 of its people have been promoted to partner effective 1 January across a network of ...

Press Releases

Hogan Lovells advises Novartis in respiratory cell therapy licensing deal with Mesoblast

Washington, D.C., 23 November 2020 – Global law firm Hogan Lovells has advised international pharmaceutical company Novartis in connection with an exclusive worldwide license and...

Press Releases

Hogan Lovells advises Novartis on Vedere Bio acquisition

New York, 10 November 2020 – International law firm Hogan Lovells is advising Novartis on its acquisition of Vedere Bio, a transaction which will add a powerful new platform for...

Press Releases

Hogan Lovells represents Bausch Health in acquiring option to purchase all ophthalmology assets of Allegro Ophthalmics

New York-  Hogan Lovells is representing Bausch Health Companies Inc. through its affiliate, Bausch + Lomb, its leading global eye health business, in an agreement with Allegro...

Press Releases

Hogan Lovells advises Arm in US$40 billion sale to NVIDIA

Hogan Lovells is advising Arm Limited (Arm), the UK-headquartered multinational semiconductor and software design company of SoftBank Group Corp. and SoftBank Vision Fund, in the US$40...

Press Releases

Hogan Lovells represents Novartis in Collaboration and Exclusive Option Agreement with IFM Therapeutics

International law firm Hogan Lovells team advised Swiss pharmaceuticals company Novartis in a collaboration and option agreement with IFM Due, a subsidiary of Boston-based biopharmaceutical ...

Press Releases

Hogan Lovells Advises IBM In Acquisition of Red Hat, Inc.

Washington D.C. and London, 9 July 2019 – Hogan Lovells advised International Business Machines Corp. (NYSE: IBM) as antitrust counsel in its US$34...

Loading data